HSBC Venture Healthcare Reports

Back to HSBC Innovation Banking

Available Reports

Providing an in-depth overview of investment activity, valuations, and step-ups for venture-backed healthcare companies.

1H 2024 Venture Healthcare Report

In 2023, venture healthcare faced a challenging IPO market and limited M&A opportunities, grappling with the valuation and investment froth from 2020-1H 2022. However, 1H 2024 saw increased investment across every sector and numerous new investor-led financings.

Download the 2023 Annual Report

The healthcare market stabilized in 2023. The rate of new investments fell 28%, however, the top 10% of deals still successfully secured substantial funding rounds with step-up valuations. A significant contingent of companies raised new rounds at revised valuations, adhering to the notion that a “flat valuation is the new up-round”.

Download the 1H 2023 Report

In the first half of 2023, as valuations underwent a necessary reset, Venture Capitalists (“VCs”) emerged from their cautious stance and embarked on a fresh wave of investments. These VCs, buoyed by recently raised funds in 2021-2022, assumed the role of leading later-stage rounds, as crossover/hedge funds retreated.

Contact Us

 Cartoon of person sitting at a desk working on a laptop

Need help?

As the leading international bank in the U.S., we connect customers to opportunities and enable them to thrive